Patience? Please, I think we've demonstrated a fair amount of patience thus far. The company has been listed for 16 years and has not one product available for sale in the US.
Assuming success of the completed heart and back P3s, I don't recall anyone talking about the possibility of further P3s being required by the FDA (unless of course the trials had missed their primary end points but demonstrated efficancy elswhere).
The announcements re. both these indications will be very important for the company. If Covid had never happened and these were still our two blockbaster shots on goal there'd be red hot rage at these delays. But everyone is distracted by the hope of getting rich on a positive ARDS announcement.
Regenerative Medicine and Cell Therapies Virtual Event, page-51
-
- There are more pages in this discussion • 79 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
0.025(2.70%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 96.8¢ | 93.5¢ | $4.207M | 4.417M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 42268 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.0¢ | 48002 | 3 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |